These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38749591)

  • 21. Two-year outcomes after deployment of XIENCE V everolimus-eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: a report from the SPIRIT V single arm study.
    Džavík V; Kaul U; Guagliumi G; Chevalier B; Smits PC; Stuteville M; Li D; Sudhir K; Grube E
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E163-72. PubMed ID: 23225766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the metal-to-artery ratio on clinical outcomes in left main and nonleft main bifurcation: insights the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life).
    Iannaccone M; D'Ascenzo F; Gatti P; Cerrato E; Nuñez-Gil I; Wojakowski W; Capodanno D; Figini F; Wańha W; Chieffo A; De Ferrari GM; Di Mario C
    J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):669-674. PubMed ID: 32639328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes at 1 Year of Non-Left Main Trunk Bifurcation Lesions Treated With a 2-Stent Strategy Using Newer-Generation Everolimus-Eluting Stents.
    Okabe K; Ohya M; Ikuta A; Takamatsu M; Osakada K; Shimada T; Miura K; Kubo S; Tada T; Tanaka H; Fuku Y; Katoh H; Kadota K
    Circ J; 2021 Oct; 85(11):1972-1980. PubMed ID: 34349075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optical Coherence Tomography Tissue Coverage and Characterization with Grey-Scale Signal Intensity Analysis After Bifurcation Stenting with a New Generation Bioabsorbable Polymer Drug-Eluting Stent.
    Rai H; Hussein H; Colleran R; Xhepa E; Wiebe J; Pinieck S; Cassese S; Joner M; Kastrati A; Byrne RA; Foley DP
    Cardiovasc Revasc Med; 2020 Mar; 21(3):277-285. PubMed ID: 31155492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.
    Zuk G; Ciecwierz D; Drewla P; Gruchała M; Gutiérrez-Chico JL; Jaguszewski M
    Cardiol J; 2019; 26(3):304-306. PubMed ID: 31246271
    [No Abstract]   [Full Text] [Related]  

  • 26. Outcomes With Intravascular Ultrasound-Guided Stent Implantation: A Meta-Analysis of Randomized Trials in the Era of Drug-Eluting Stents.
    Elgendy IY; Mahmoud AN; Elgendy AY; Bavry AA
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003700. PubMed ID: 26980883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual Antiplatelet Therapy Duration Determines Outcome After 2- But Not 1-Stent Strategy in Left Main Bifurcation Percutaneous Coronary Intervention.
    Rhee TM; Park KW; Kim CH; Kang J; Han JK; Yang HM; Kang HJ; Koo BK; Kim HS
    JACC Cardiovasc Interv; 2018 Dec; 11(24):2453-2463. PubMed ID: 30573055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of side branch stenting on five-year long-term clinical outcome with the bifurcation-dedicated Axxess Biolimus A9-eluting stent system.
    Verheye S; Buysschaert I; Grube E
    EuroIntervention; 2015 Dec; 11(8):860-7. PubMed ID: 26696454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Provisional side branch-stenting for coronary bifurcation lesions: evidence of improving procedural and clinical outcomes with contemporary techniques.
    Mylotte D; Routledge H; Harb T; Garot P; Hovasse T; Benamer H; Unterseeh T; Chevalier B; Morice MC; Louvard Y; Lefèvre T
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E437-45. PubMed ID: 23441082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravascular ultrasound-guided drug-eluting stent implantation is associated with improved clinical outcomes in patients with unstable angina and complex coronary artery true bifurcation lesions.
    Chen L; Xu T; Xue XJ; Zhang JJ; Ye F; Tian NL; Chen SL
    Int J Cardiovasc Imaging; 2018 Nov; 34(11):1685-1696. PubMed ID: 29981016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why double-kissing crush should be preferred over culotte for two-stent bifurcation stenting.
    Simsek B; Brilakis ES
    Catheter Cardiovasc Interv; 2022 Jun; 99(7):2006-2007. PubMed ID: 35674103
    [No Abstract]   [Full Text] [Related]  

  • 32. Very late stent thrombosis in everolimus-eluting stent with predisposing mechanical factors: Differential features.
    Jaguszewski MJ; Cortes C; Daucher H; Schincariol M; Halejcio M; Besuch P; Gutiérrez-Chico JL
    Cardiol J; 2017; 24(4):345-349. PubMed ID: 28831778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Case-Control analysis of a dedicated self-expanding Biolimus A9-eluting Bifurcation stent versus provisional or mandatory side branch intervention strategies in the treatment of coronary bifurcation lesions.
    Ohlow MA; Farah A; Richter S; El-Garhy M; von Korn H; Lauer B
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):39-47. PubMed ID: 27651317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The complexity of stenting in bifurcation coronary lesions.
    Kornowski R
    JACC Cardiovasc Interv; 2013 Jul; 6(7):696-7. PubMed ID: 23866181
    [No Abstract]   [Full Text] [Related]  

  • 35. New-Generation Drug-Eluting Stents for Left Main In-Stent Restenosis: The DELTA-2 Registry.
    Giustino G; Tanaka A; Erglis A; Morice MC; Van Mieghem NM; Meliga E; D'Ascenzo F; Stefanini GG; Capodanno D; Chieffo A;
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2438-2440. PubMed ID: 30522680
    [No Abstract]   [Full Text] [Related]  

  • 36. Dedicated Bifurcation Stents vs. Conventional Stenting Strategy for Coronary Bifurcation Lesions: Insights from Randomized Clinical Trials.
    Rawasia WF; Alkhouli M
    Cardiovasc Revasc Med; 2020 Apr; 21(4):556-558. PubMed ID: 31928939
    [No Abstract]   [Full Text] [Related]  

  • 37. Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study.
    Worthley S; Hendriks R; Worthley M; Whelan A; Walters DL; Whitbourn R; Meredith I
    Cardiovasc Revasc Med; 2015; 16(7):413-7. PubMed ID: 26346023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiographic and clinical outcome after crush of everolimus-eluting stent for distal unprotected left main disease.
    Migliorini A; Valenti R; Vergara R; Grazia De Gregorio M; Gabrielli E; De Vito E; Raffaella Aicale M; Carrabba N; Antoniucci D
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):72-77. PubMed ID: 28707445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions.
    Abdel-Wahab M; Toelg R; Byrne RA; Geist V; El-Mawardy M; Allali A; Rheude T; Robinson DR; Abdelghani M; Sulimov DS; Kastrati A; Richardt G
    Circ Cardiovasc Interv; 2018 Oct; 11(10):e007415. PubMed ID: 30354632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.